NCT02496585 2025-04-16
Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
AstraZeneca
Centre hospitalier de l'Université de Montréal (CHUM)
VA Office of Research and Development
Centre Leon Berard
M.D. Anderson Cancer Center